The FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy, approved in September, includes several measures to train health professionals on the use of opioid medications and their risks. The ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Mary Williams, a 42-year-old receptionist and mother of three, has a complicated ...
The main solution to the nation's opioid abuse epidemic is for pharma companies to devise educational programs for physicians on the dangers of overuse, misuse, and abuse of these widely used ...
TALLAHASSEE, Fla., March 14, 2011 /PRNewswire/ -- LearnSomething today announced the offering of their first Risk Evaluation and Mitigation Strategy(REMS) pharmacy training program for Abstral, an ...
Please provide your email address to receive an email when new articles are posted on . The FDA can require a safety program called a Risk Evaluation and Mitigation Strategy, or REMS, for a medication ...
The US Food and Drug Administration (FDA) recently released new guidance on counseling patients who may be prescribed or are currently taking drugs with a Risk Evaluation and Mitigation Strategy, or ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results